PHG

Koninklijke Philips N.V.

$30.41

-1.23%
SectorHealthcareIndustryMedical DevicesCountryNetherlands

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Source: Yahoo Finance
AI summary

Price & performance

1M+29.8%
3M+17.3%
YTD+19.2%
1Y+15.2%
52-week range—
Beta0.82
Full chart and returns against a benchmark

Q-Score

72/ 100

Quality against peers; 50 is the peer median.

Growth58
Risk78
Performance60
Valuation70
Profitability64
Leverage52
Sentiment19
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$21B+11.7%
Net income$1.1B
Net margin5.0%+8.9 pts
Historical fundamentals

Revenue exposure

60%of revenue from outside the US
United States40%
Other countries30%
Netherlands14%
Regions, segments, customers and suppliers

Valuation

PHGIndustryP/E28.2129.61P/S1.423.49EV/EBITDA11.9818.38P/B2.313.39PEG——
Dividend yield1.30%
Every valuation metric

Earnings

Nov 3next report, before the open
EPS estimate$0.36
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate